Robaxin and Xanthoma - a phase IV clinical study of FDA data
We study 8,758 people who take Robaxin or have Xanthoma. No report of Xanthoma is found in people who take Robaxin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Robaxin?
Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 8,358 Robaxin users for its effectiveness, alternative drugs and more.
What is Xanthoma?
Xanthoma (deposition of yellowish cholesterol in skin) is found to be associated with 371 drugs and 276 conditions by eHealthMe.
Do you take Robaxin and have Xanthoma?Check whether Xanthoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Xanthoma and when was it recovered:
Expand to all the drugs that have ingredients of methocarbamol:
Alternative drugs to, pros and cons of Robaxin:
- Robaxin (8,358 reports)
Xanthoma treatments and more:
- Xanthoma (400 reports)
COVID vaccines that are related to Xanthoma:
- Xanthoma in Moderna COVID Vaccine
- Xanthoma in Pfizer BioNTech Covid Vaccine
- Xanthoma in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Xanthoma:
All the conditions that are associated with Xanthoma:
How the study uses the data?
The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Broccoli and Paraesthesia - 5 seconds ago
- Dermatitis and Coughing Up Blood - 9 seconds ago
- Vitamin E and Pancreatic Necrosis - 10 seconds ago
- Plan B One-Step and Stelara drug interaction - 12 seconds ago
- Ramipril and Lapatinib Ditosylate drug interaction - 16 seconds ago
- Hallucinations and Red Blood Cell Count Decreased - 16 seconds ago
- Retin-A and Osteonecrosis Of Jaw - 20 seconds ago
- Esomeprazole Magnesium and Renal Failure Acute - 20 seconds ago
- Neumega and Blood Creatinine Increased - 30 seconds ago
- Bydureon Bcise and Macrobid drug interaction - 30 seconds ago